Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
2
What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics
3
New Useful Insights: Analysis of Data From Phase 3 Clinical Trials Evaluating Simufilam for Mild-to-Moderate Alzheimer Disease
4
FDA Issues Removal of Suicidal Behavior and Ideation Warning From GLP-1 RAs
5













